Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Fortis Healthcare Holdings Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 Allotment of Equity Shares
Fortis Healthcare Ltd has informed BSE that the Nomination and Remuneration Committee of the Company has approved allotment of 30700 Equity Shares of Rs. 10/- each, to the grantees, upon exercise of vested stock options.Consequent to the said allotment, the paid-up equity share capital of the Company stands increased to Rs. 4,629,714,940/- divided into 462,971,494 equity shares of Rs. 10/- each. Q2 results on Nov 04, 2015
Fortis Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 04, 2015, inter-alia, to approve the Un-Audited Financial Results of the Company, for the Quarter and Half Year ended September 30, 2015 (Q2).Further, the trading window of the Company for dealing in securities of the Company will remain closed from October 28, 2015 to November 06, 2015. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Fotris Healthcare Holdiings Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Fortis Healthcare Holdings Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE FEHI research shows superiority of one drug eluting stent over another in diabetics
The findings of the research were presented at the trans-catheter cardiovascular therapeutics (TCT) conference in San Francisco, US Prof Upendra Kaul, Dean & Executive Director, Cardiology and Academics & Research Department, Fortis Escorts Heart Institute and Fortis Flt Lt Rajan Dhall Hospital presented research that clearly demonstrated the superiority of everolimus eluting stents over Paclitaxel [] Shareholding Pattern For September 30, 2015
Fortis Healthcare Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015. Updates on Outcome of AGM
Fortis Healthcare Ltd has submitted to BSE a copy of Proceedings of the 19th Annual General Meeting (AGM) of the Company held on September 23, 2015. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
IL&FS; Trust Company Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011